| 6DCF | date | ![]() |
|||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||||||||||||||||||
| compound | source | ||||||||||||||||||||||||||||||
| symmetry |
| ||||||||||||||||||||||||||||||
| crystal cell |
| ||||||||||||||||||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||||||||||||||||||
| ligand | EDO, GLU, KNG, MG, SO4, ZN | enzyme |
| ||||||||||||||||||||||||||||
| Gene Ontology |
| ||||||||||||||||||||||||||||||
| Primary reference | Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism., Peek J, Lilic M, Montiel D, Milshteyn A, Woodworth I, Biggins JB, Ternei MA, Calle PY, Danziger M, Warrier T, Saito K, Braffman N, Fay A, Glickman MS, Darst SA, Campbell EA, Brady SF, Nat Commun. 2018 Oct 8;9(1):4147. doi: 10.1038/s41467-018-06587-2. PMID:30297823 | ||||||||||||||||||||||||||||||
| Data retrieval |
![]() |
| View 6DCF in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |